Literature DB >> 27278835

A symptomatic child with ceftriaxone-associated biliary pseudolithiasis.

Naoki Kutuya1, Yutaka Ozaki2, Tadaharu Okazaki3.   

Abstract

A 5-year-old boy who had pneumonia was treated in a neighboring hospital. Ceftriaxone was administrated 2 g/day divided into two equal intravenous doses. After 1 week of ceftriaxone therapy, the patient developed abdominal pain. In our hospital, an abdominal sonogram showed a hyperechoic band with postacoustic shadow within the collapsed gallbladder. He was diagnosed with ceftriaxone-associated biliary pseudolithiasis, and ceftriaxone therapy was ceased. On the 8th our hospital day, he again complained of right abdominal pain after supper. A sonogram revealed high-amplitude echoes within the gallbladder neck and common bile duct. Furthermore, bile duct dilatation was observed. He was managed conservatively, after which the symptoms were resolved. On the 11th day, a sonogram showed only sludge within the gallbladder, and on the 13th day, he was discharged from our hospital. It is important for sonographers to recognize the possible occurrence of biliary pseudolithiasis in ceftriaxone-treated patients, especially when a high dose is used in children.

Entities:  

Keywords:  biliary pseudolithiasis; ceftriaxone; child; ultrasonography

Year:  2008        PMID: 27278835     DOI: 10.1007/s10396-008-0170-6

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  22 in total

1.  Reversible ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  U B Schaad; J Wedgwood-Krucko; H Tschaeppeler
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

2.  Ceftriaxone-associated biliary pseudolithiasis in adults.

Authors:  C Pigrau; A Pahissa; S Gropper; D Sureda; J M Martinez Vazquez
Journal:  Lancet       Date:  1989-07-15       Impact factor: 79.321

3.  Incidence of ceftriaxone-associated gallbladder pseudolithiasis.

Authors:  F Papadopoulou; S Efremidis; S Karyda; M Badouraki; E Karatza; C Panteliadis; K Malaka
Journal:  Acta Paediatr       Date:  1999-12       Impact factor: 2.299

4.  Ceftriaxone-associated cholecystitis.

Authors:  R F Jacobs
Journal:  Pediatr Infect Dis J       Date:  1988-06       Impact factor: 2.129

5.  Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy.

Authors:  U B Schaad; H Tschäppeler; M J Lentze
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

6.  A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children.

Authors:  U B Schaad; S Suter; A Gianella-Borradori; J Pfenninger; R Auckenthaler; O Bernath; J J Cheseaux; J Wedgwood
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

7.  Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate.

Authors:  H Z Park; S P Lee; A L Schy
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

8.  Apparent biliary pseudolithiasis during ceftriaxone therapy.

Authors:  K L Heim-Duthoy; E M Caperton; R Pollock; G R Matzke; D Enthoven; P K Peterson
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

9.  Ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  Betül Biner; Naci Oner; Coşkun Celtik; Musa Bostancioğlu; Nermin Tunçbilek; Ahmet Güzel; Serap Karasalihoğlu
Journal:  J Clin Ultrasound       Date:  2006-06       Impact factor: 0.910

10.  Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.

Authors:  Jeffrey S Prince; Melvin O Senac
Journal:  Pediatr Radiol       Date:  2003-06-26
View more
  2 in total

1.  Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction.

Authors:  Aya Imafuku; Naoki Sawa; Akinari Sekine; Masahiro Kawada; Rikako Hiramatsu; Masayuki Yamanouchi; Eiko Hasegawa; Noriko Hayami; Jyunichi Hoshino; Yoshifumi Ubara; Kenmei Takaichi
Journal:  Clin Exp Nephrol       Date:  2017-10-12       Impact factor: 2.801

Review 2.  Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis.

Authors:  Alicja Bartkowska-Śniatkowska; Katarzyna Jończyk-Potoczna; Marzena Zielińska; Jowita Rosada-Kurasińska
Journal:  Ther Clin Risk Manag       Date:  2015-07-02       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.